Effectsof Estrone, Estradiol,and Estriolon Hormone responsiveHuman Breast Cancer in Long-TermTissue Cultureâ€
暂无分享,去创建一个
[1] C. Osborne,et al. In vitro model systems for the study of hormone-dependent human breast cancer. , 1977, The New England journal of medicine.
[2] M. Lippman,et al. A simple computer program for quantitation and Scatchard analysis of steroid receptor proteins. , 1977, Journal of steroid biochemistry.
[3] C. Osborne,et al. Hormone responsive human breast cancer in long-term tissue culture: effect of insulin. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[4] M. Lippman,et al. A demonstration of androgen and estrogen receptors in a human breast cancer using a new protamine sulfate assay , 1976, Cancer.
[5] H. Bradlow,et al. Hormone profiles in hormone-dependent cancers. , 1975, Cancer research.
[6] H. Lemon. Estriol prevention of mammary carcinoma induced by 7,12-dimethylbenzanthracene and procarbazine. , 1975, Cancer research.
[7] B. Mobbs,et al. Estrogen-binding in vitro by DMBA-induced rat mammary tumors: its relationship to hormone responsiveness. , 1974, European journal of cancer.
[8] W. McGuire,et al. Improved sensitivity in the measurement of estrogen receptor in human breast cancer. , 1973, The Journal of clinical endocrinology and metabolism.
[9] A. Long,et al. A human cell line from a pleural effusion derived from a breast carcinoma. , 1973, Journal of the National Cancer Institute.
[10] G. Flickinger,et al. Column chromatography of steroids on Sephadex LH-20. , 1971, The Journal of clinical endocrinology and metabolism.
[11] D. Griswold,et al. Studies of the kinetics of growth and regression of 7,12-dimethylbenz(alpha)anthracene-induced mammary adenocarcinoma in Sprague-Dawley rats. , 1970, Cancer research.
[12] J. Adams,et al. PARAENDOCRINE BEHAVIOUR OF HUMAN BREAST CARCINOMA: IN VITRO TRANSFORMATION OF STEROIDS TO PHYSIOLOGICALLY ACTIVE HORMONES , 1968 .
[13] P. Mozden,et al. Reduced estriol excretion in patients with breast cancer prior to endocrine therapy. , 1966, JAMA.
[14] C. Hopkins,et al. II. URINARY EXCRETION OF ESTRONE, ESTRADIOL, AND ESTRIOL BY PATIENTS WITH BREAST CANCER AND BENIGN BREAST DISEASE. , 1965, American journal of obstetrics and gynecology.
[15] C. Hopkins,et al. URINARY EXCRETION OF ESTRONE, ESTRADIOL AND ESTRIOL BY PATIENTS WITH PROSTATIC CANCER AND BENIGN PROSTATIC HYPERTROPHY. , 1965, The Journal of urology.
[16] L. Risholm,et al. OOPHORECTOMY AND CORTISONE TREATMENT AS A METHOD OF ELIMINATING OESTROGEN PRODUCTION IN PATIENTS WITH BREAST CANCER. , 1964, Acta endocrinologica.
[17] G. Bacigalupo,et al. [Studies on the estrogen excretion in urine in mastopathy]. , 1960, Klinische Wochenschrift.
[18] I. Bersohn,et al. Urinary oestrogen levels in myocardial infarction. , 1958, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[19] E. Jensen,et al. THE DEPRESSION OF ESTRONE-INDUCED UTERINE GROWTH BY PHENOLIC ESTROGENS WITH OXYGENATED FUNCTIONS AT POSITIONS 6 OR 16: THE IMPEDED ESTROGENS , 1955, The Journal of experimental medicine.
[20] F. Hisaw,et al. Interaction of estrogens on uterine growth. , 1954, The Journal of clinical endocrinology and metabolism.
[21] G. Scatchard,et al. THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .